Opioid Market Size, Trends, Analysis, and Outlook By Product (IR/Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain relief, Anesthesia, Cough suppression, Diarrhea suppression, De-addiction), By Route of Administration (Oral, Injectable,

Opioid Market Size, Trends, Analysis, and Outlook By Product (IR/Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain relief, Anesthesia, Cough suppression, Diarrhea suppression, De-addiction), By Route of Administration (Oral, Injectable, Others), Opioids Distribution Channel, Hospital pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030

The global Opioid market size is poised to register 3.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Opioid market across By Product (IR/Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain relief, Anesthesia, Cough suppression, Diarrhea suppression, De-addiction), By Route of Administration (Oral, Injectable, Others), Opioids Distribution Channel, Hospital pharmacy, Retail Pharmacy, Others).

The Opioid market is witnessing significant scrutiny and transformation due to the opioid epidemic, regulatory interventions, and shifting prescribing patterns worldwide. Opioids are a class of drugs primarily used for pain management, including acute and chronic pain conditions, but they are also associated with significant risks of abuse, addiction, overdose, and mortality. Key factors influencing the opioid market include the rising awareness about the public health crisis associated with opioid misuse and addiction, the implementation of prescription drug monitoring programs (PDMPs) and opioid prescribing guidelines, and the efforts to expand access to non-opioid pain management alternatives and addiction treatment services. Additionally, the growing emphasis on opioid stewardship and risk mitigation strategies, the development of abuse-deterrent formulations and opioid reversal agents, and the regulatory actions to restrict opioid prescribing and curb illicit opioid supply are driving changes in the market landscape. Moreover, the increasing adoption of multidisciplinary pain management approaches, the integration of behavioral health services and medication-assisted treatment (MAT) programs, and the expansion of telemedicine and digital health solutions for addiction care and recovery support are shaping the future of the opioid market. Furthermore, the ongoing research and development efforts to discover novel analgesic compounds with improved safety profiles and reduced abuse potential, the implementation of evidence-based interventions to address social determinants of health and opioid-related stigma, and the collaboration between government agencies, healthcare providers, and community stakeholders are critical for addressing the complex challenges associated with opioids. With the evolving regulatory environment and the growing recognition of the need for comprehensive opioid harm reduction strategies, the opioid market is undergoing significant transformation to prioritize patient safety, public health, and equitable access to pain management and addiction care services.

Opioid Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Opioid market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Opioid survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Opioid industry.

Key market trends defining the global Opioid demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Opioid Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Opioid industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Opioid companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Opioid industry

Leading Opioid companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Opioid companies.

Opioid Market Study- Strategic Analysis Review

The Opioid market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Opioid Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Opioid industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Opioid Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Opioid Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Opioid market segments. Similarly, Strong end-user demand is encouraging Canadian Opioid companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Opioid market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Opioid Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Opioid industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Opioid market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Opioid Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Opioid in Asia Pacific. In particular, China, India, and South East Asian Opioid markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Opioid Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Opioid Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Opioid market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Opioid.

Opioid Market Company Profiles

The global Opioid market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, AcelRx Pharmaceuticals Inc, Alcaliber SA, Amneal Pharmaceuticals Inc, Endo Pharmaceuticals Inc, Hikma Pharmaceuticals PLC, Johnson and Johnson, Mallinckrodt Pharmaceuticals LLC, Pfizer Inc, Purdue Pharmaceuticals L.P., Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals Inc, Vertice Pharma LLC, Zyla Life Sciences

Recent Opioid Market Developments

The global Opioid market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Opioid Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

IR/Short Acting Opioids

ER/Long-Acting Opioids

By IR/Short Acting Opioids

Immediate- Release/Short-Acting Opioid by Product

-Codeine

-Oxycodone

-Hydrocodone

-Fentanyl

-Morphine

-Hydroxymorphone

-Oxymorphone

-Propoxyphene

-Others

Immediate- Release/Short-Acting Opioid by Application

-Pain relief

-Anesthesia

-Cough suppression

-Diarrhea suppression

-De-addiction

By ER/Long-Acting Opioids

Extended-Release/Long-Acting Opioid by Product

-Codeine

-Oxycodone

-Hydrocodone

-Fentanyl

-Morphine

-Hydroxymorphone

-Oxymorphone

-Propoxyphene

-Others

Extended-Release/Long-Acting Opioid by Application

-Pain relief

-Anesthesia

-Cough suppression

-Diarrhea suppression

-De-addiction

By Application

Pain relief

Anesthesia

Cough suppression

Diarrhea suppression

De-addiction

By Route of administration

Oral

Injectable

Others

Opioids Distribution Channel

Hospital pharmacy

Retail Pharmacy

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

AbbVie Inc

AcelRx Pharmaceuticals Inc

Alcaliber SA

Amneal Pharmaceuticals Inc

Endo Pharmaceuticals Inc

Hikma Pharmaceuticals PLC

Johnson and Johnson

Mallinckrodt Pharmaceuticals LLC

Pfizer Inc

Purdue Pharmaceuticals L.P.

Sun Pharmaceutical Industries Ltd

Teva Pharmaceuticals Inc

Vertice Pharma LLC

Zyla Life Sciences

Formats Available: Excel, PDF, and PPT